Inactivation of the gene for anticoagulant protein C causes lethal perinatal consumptive coagulopathy in mice

Journal of Clinical Investigation

Volumn 102, Issue 8, 1998, Pages 1481-1488

  Jalbert, Louise R ^a,b   Rosen, Elliot D ^b   Moons, Lieve ^a   Chan, Joyce C Y ^a,b   Carmeliet, Peter ^a   Collen, Désiré ^a   Castellino, Francis J ^b  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b UNIVERSITY OF NOTRE DAME   (United States)

Author keywords

Coagulation; Embryonic development; Gene deletion; Inflammation; Protein C deficiency

Indexed keywords

PROTEIN C;

ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; GENE DELETION; GENE MAPPING; GENE REPRESSION; HISTOPATHOLOGY; LIVER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN C DEFICIENCY;

EID: 0032532678     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI3011     Document Type: Article

References (47)

1. Tanabe, S., T. Sugo, and M. Matsuda. 1991. Synthesis of protein C in human umbilical vein endothelial cells. J. Biochem. 109:924-928.
2. He, X.H., L. Shen, A. Bjartell, J. Malm, H. Lilja, and B. Dahlback. 1995. The gene encoding vitamin K-dependent anticoagulant protein C is expressed in human male reproductive tissues. J. Histochem. Cytochem. 43:563-570.
3. Jamison, C.S., S.A. McDowell, R.A. Marlar, and S.J.F. Degen. 1995. Developmental expression of protein C and protein S in the rat. Thromb. Res. 78: 407-419.
4. Foster, D.C., and E.W. Davie. 1984. Characterization of a cDNA coding for human protein C. Proc. Natl. Acad. Sci. USA. 81:4766-4770.
5. Foster, D.C., S. Yoshitake, and E.W. Davie. 1985. The nucleotide sequence of the gene for human protein C. Proc. Natl. Acad. Sci. USA. 82:4673-4677.
6. Yoshitake, S., B.C. Schach, D.C. Foster, E.W. Davie, and K. Karachi. 1985. Nucleotide sequence of the gene for human factor IX (antihemophilic factor B). Biochemistry. 24:3736-3750.
7. Leytus, S.P., D.C. Foster, K. Kurachi, and E.W. Davie. 1986. Gene for human factor X: a blood coagulation factor whose gene organization is essentially identical with that of factor IX and protein C. Biochemistry. 25:5098-5102.
8. O'Hara, P.J., F.J. Grant, B.A. Haldeman, C.L. Gray, M.Y. Insley, F.S. Hagen, and M.J. Murray. 1987. Nucleotide sequence of the gene coding for human factor VII, a vitamin K-dependent protein participating in blood coagulation. Proc. Natl. Acad. Sci. USA. 84:5158-5162.
9. Esmon, N.L., W.G. Owen, and C.T. Esmon. 1982. Isolation of a membrane-bound cofactor for thrombin-catalyzed activation of protein C. J. Biol. Chem. 257:859-864.
10. Kisiel, W., W.M. Canfield, L.H. Ericsson, and E.W. Davie. 1977. Anticoagulant properties of bovine plasma protein C following activation by thrombin. Biochemistry. 16:5824-5831.
11. Stenflo, J., and P. Fernlund. 1982. Amino acid sequence of the heavy chain of bovine protein C. J. Biol. Chem. 257:12180-12190.
12. Vehar, G.A., and E.W. Davie. 1980. Preparation and properties of bovine factor VIII (antihemophilic factor). Biochemistry. 19:401-410.
13. Bajzar, L., M. Kalafatis, P. Simioni, and P.B. Tracy. 1996. An antifibrinolytic mechanism describing the prothrombotic effect associated with factor V-Leiden. J. Biol. Chem. 271:22949-22952.
14. Taylor, F.B., and M.S. Lockhart. 1985. A new function for activated protein C: activated protein C prevents inhibition of plasminogen activators by releasate from mononuclear leukocytes-platelet suspensions stimulated by phorbol diester. Thromb. Res. 37:639-649.
15. D'Angelo, A., M.S. Lockhart, S.V. D'Angelo, and F.B. Taylor. 1987. Protein S is a cofactor for activated protein C neutralization of an inhibitor of plasminogen activation released from platelets. Blood. 69:231-237.
16. Esmon, C.T., F.B. Taylor, and T.R. Snow. 1991. Inflammation and coagulation: linked processes potentially regulated through a common pathway mediated by protein C. Thromb. Haemost. 66:160-165.
17. Grey, S.T., A. Tsuchida, H. Hau, C.L. Orthner, H.H. Salem, and W.W. Hancock. 1994. Selective inhibitory effects of the anticoagulant activated protein C on the responses of human mononuclear phagocytes to LPS, IFN-γ, or phorbol ester. J. Immunol. 153:3664-3672.
18. Dahlback, B. 1995. The protein C anticoagulant system: inherited defects as basis for venous thrombosis. Thromb. Res. 77:1-43.
19. Tuddenham, E.G.D., T. Takase, A.E. Thomas, A.S. Awidi, F.F. Madanat, M.M. Abu Hajir, P.B.A. Kernoff, and A.V. Hoffbrand. 1989. Homozygous protein C deficiency with delayed onset of symptoms at 7 to 10 months. Thromb. Res. 53:475-484.
20. Marlar, R. A., and A. Neumann. 1990. Neonatal purpura fulminans due to homozygous protein C or protein S deficiencies. Semin. Thromb. Hemost. 16: 299-309.
21. Awidi, A.S., M. Abu-Khalaf, U. Herzallah, A. Abu-Rajab, M.M. Shannak, T. Abu-Obeid, I. al-Taher, and B. Anshasi. 1993. Hereditary thrombophilia among 217 consecutive patients with thromboembolic disease in Jordan. Am. J. Hematol. 44:95-100.
22. Berdeaux, D.H., T.C. Abshire, and R.A. Marlar. 1993. Dysfunctional protein C deficiency (type II). A report of 11 cases in three American families and review of the literature. Am. J. Clin. Pathol. 99:677-686.
23. Soria, J.M., M. Morell, C. Jimenezastorga, X. Estivill, and N. Sala. 1995. Severe type I protein C deficiency in a compound heterozygote for Y124C and Q132X mutations in exon 6 of the PROC gene. Thromb. Haemost. 74:1215-1220.
24. Gerson, W.T., J.D. Dickerman, E.G. Bovill, and E. Golden. 1993. Severe acquired protein C deficiency in purpura fulminans associated with disseminated intravascular coagulation. Treatment with protein C concentrate. Pediatrics. 91:418-422.
25. Nachman, R.L., and R. Silverstein. 1993. Hypercoagulable states. Ann. Intern. Med. 119:819-827.
26. Cransac, M., J. Carles, P.H. Bernard, P. Malavialle, G. Freyburger, S. Winnock, and J. Saric. 1995. Heterozygous protein C deficiency and dysfibrinogenemia acquired by liver transplantation. Transpl. Int. 8:307-311.
27. Jalbert, L.R., E.D. Rosen, A. Lissens, P. Carmeliet, D. Collen, and F.J. Castellino. 1998. Nucleotide structure and characterization of the murine gene encoding anticoagulant protein C. Thromb. Haemost. 79:310-316.
28. 7D) of human activated protein C displays greatly reduced activity as an anticoagulant. Biochemistry. 29:10828-10834.
29. Mullen, C.A., M. Kilstrup, and R.M. Blaese. 1992. Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: a negative selection system. Proc. Natl. Acad, Sci. USA. 89:33-37.
30. Konecki, D.S., J. Brennand, J.C. Fuscoe, C.T. Caskey, and A.C. Chinault. 1982. Hypoxanthine-guanine phosphoribosyltransferase genes of mouse and Chinese hamster construction and sequence analysis of cDNA recombinants. Nucleic Acids Res. 10:6763-6775.
31. Nagy, A., J. Rossant, R. Nagy, W. Abramow-Newerly, and J.C. Roder. 1993. Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc. Natl. Acad. Sci. USA. 90:8424-8428.
32. Wood, S.A., N.D. Allen, J. Rossant, A. Auerbach, and A. Nagy. 1993. Non-injection methods for the production of embryonic stem cell-embryo chimaeras. Nature. 365:87-59.
33. Orthner, C.L., P. Bhattacharya, and O.K. Strickland. 1988. Characterization of a protein C activator from the venom of Agkistrodon contortrix contortrix. Biochemistry. 27:2558-2564.
34. Healy, A.M., H.B. Rayburn, R.D. Rosenberg, and H. Weiler. 1995. Absence of the blood-clotting regulator thrombomodulin causes embryonic lethality in mice before development of a functional cardiovascular system. Proc. Natl. Acad. Sci. USA. 92:850-854.
35. Weiler-Guettler, H., P.D. Christie, D.L. Beeler, A.M. Healy, W.W. Hancock, H. Rayburn, J.M. Edelberg, and R.D. Rosenberg. 1998. A targeted point mutation in thrombomodulin generates viable mice with a prethrombotic state. J. Clin. Invest. 101:1983-1991.
36. Rezaie, A.R. 1998. Rapid activation of protein C by factor Xa and thrombin in the presence of polyanionic compounds. Blood. 91:4572-4580.
37. Suh, T.T., K. Holmback, N.J. Jensen, C.C. Daugherty, K. Small, D.I. Simon, S. Potter, and J. Degen. 1995. Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice. Genes Dev. 9:2020-2030.
38. Rosen, E., J.C.Y. Chan, E. Idusogie, F. Clotman, G. Vlasuk, T. Luther, L. Jalbert, S. Albrecht, L. Zhong, A. Lissens, et al. 1997. Mice lacking factor VII develop normally but suffer fatal perinatal bleeding. Nature. 390:290-294.
39. Bi, L., A.M. Lawler, S.E. Antonarakis, K.A. High, J.D. Gearhart, and H.H. Kazazian. 1995. Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A. Nat. Genet. 10:119-121.
40. Lin, H.F., N. Maeda, O. Smithies, D.L. Staright, and D.W. Stafford. 1997. A coagulation factor IX-deficient mouse model for human hemophilia B. Blood. 90:3962-3966.
41. Shivdasani, R.A., M.F. Rosenblatt, D. Zucker-Franklin, C.W. Jackson, P. Hunt, C.J. Saris, and S.H. Orkin. 1995. Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin/ MGDF in megakaryocyte development. Cell. 81:695-704.
42. Sun, W.Y., D.P. Witte, J.L. Degen, M.C. Colbert, M.C. Burkart, K. Holmback, Q. Xiao, T.H. Bugge, and S.J.F. Degen. 1998. Prothrombin deficiency results in embryonic and neonatal lethality in mice. Proc. Natl. Acad. Sci. USA. 95:7597-7602.
43. Xue, J.C., Q.Y. Wu, L.A. Westfield, E.A. Tuley, D.S. Lu, Q. Zhang, K. Shim, X.L. Zheng, and J.E. Sadler. 1998. Incomplete embryonic lethality and fatal neonatal hemorrhage caused by prothrombin deficiency in mice. Proc. Natl. Acad. Sci. USA. 95:7603-7607.
44. Cui, J.S., K.S. Oshea, A. Purkayastha, T.L. Saunders, and D. Ginsburg. 1996. Fatal haemorrhage and incomplete block to embryogenesis in mice lacking coagulation factor V. Nature. 384:66-68.
45. Connolly, A.J., H. Ishihara, M.L. Kahn, R.V. Farese, and S.R. Coughlin. 1996. Role of the thrombin receptor in development and evidence for a second receptor. Nature. 381:516-519.
46. Gordon, S.G., and A.M. Mourad. 1991. The site of activation of factor X by cancer procoagulant. Blood Coagul. Fibrinolysis. 2:735-739.
47. Huang, Z.-F., D. Higuchi, N. Lasky, and G.J. Broze, Jr. 1997. Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice. Blood. 90:944-951.